Filed Pursuant to Rule 424(b)(5)
Registration No. 333-277241
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 22, 2024)
$2,000,000,000
$750,000,000 5.150% Senior Notes due 2027
$500,000,000 5.350% Senior Notes due 2031
$750,000,000 5.450% Senior Notes due 2034
We are offering
$750,000,000 principal amount of our 5.150% Senior Notes due 2027 (the 2027 notes), $500,000,000 principal amount of our 5.350% Senior Notes due 2031 (the 2031 notes) and $750,000,000 principal amount of our 5.450% Senior
Notes due 2034 (the 2034 notes and, together with the 2027 notes and the 2031 notes, the notes). The 2027 notes will mature on March 15, 2027, the 2031 notes will mature on March 15, 2031 and the 2034 notes will
mature on March 15, 2034. We will pay interest on the notes semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024.
We may, at our option, redeem each series of the notes, in whole or in part, at any time and from time to time at the applicable redemption
price described in this prospectus supplement in Description of the NotesOptional Redemption. We may also redeem each series of the notes at our option, in whole but not in part, at the applicable redemption price described in this
prospectus supplement if certain tax events occur as described in Description of the NotesOptional Tax Redemption. We must offer to repurchase the notes upon the occurrence of a change of control triggering event at the price
described in this prospectus supplement in Description of the NotesPurchase of Notes upon a Change of Control Triggering Event.
We intend to use the net proceeds from this offering to repay a portion of our 2.75% senior notes due July 1, 2024 and for general
corporate purposes, including the repayment of a portion of our commercial paper notes and share repurchases.
The offering and sale of each
series of notes is not conditioned on the sale of any other series of notes.
The notes will be our unsecured senior obligations and will
rank equally with our other unsecured senior indebtedness from time to time outstanding.
Each series of the notes is a new issue of
securities with no established trading market. We currently have no intention to apply to list the notes on any securities exchange or to seek their admission to trading on any automated quotation system.
Investing in the notes involves risks. See Risk Factors beginning on page S-7 of this prospectus supplement and the risk factors incorporated by reference into this prospectus supplement and the accompanying prospectus.
Neither the Securities and Exchange Commission (the SEC) nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price to Public(1) |
|
|
Underwriting Discounts |
|
|
Proceeds to Fiserv, Inc., Before Expenses |
|
Per 2027 note |
|
|
99.901 |
% |
|
|
0.400 |
% |
|
|
99.501 |
% |
Per 2031 note |
|
|
99.830 |
% |
|
|
0.625 |
% |
|
|
99.205 |
% |
Per 2034 note |
|
|
99.990 |
% |
|
|
0.650 |
% |
|
|
99.340 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,998,332,500 |
|
|
$ |
11,000,000 |
|
|
$ |
1,987,332,500 |
|
(1) |
Plus accrued interest if any, from March 4, 2024, if settlement occurs after that date.
|
We expect to deliver the notes to investors in registered book-entry only form through the facilities of The Depository
Trust Company (DTC) on or about March 4, 2024. Beneficial interests in the notes will be shown on, and transfers thereof will be effected only through, records maintained by DTC and its direct and indirect participants, including
Clearstream Banking, S.A., and Euroclear Bank S.A./N.V., as operator of the Euroclear system.
Joint
Book-Running Managers
|
|
|
|
|
J.P. Morgan |
|
TD Securities |
|
US Bancorp |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BofA Securities |
|
MUFG |
|
PNC Capital Markets LLC |
|
Truist Securities |
|
|
|
Wells Fargo Securities |
|
Deutsche Bank Securities |
Co-Managers
|
|
|
|
|
|
|
|
|
|
|
BMO Capital Markets |
|
Capital One Securities |
|
Mizuho |
|
NatWest Markets |
|
Santander |
|
Scotiabank |
|
|
|
|
|
|
|
|
Fifth Third Securities |
|
Huntington Capital Markets |
|
KeyBanc Capital Markets |
|
|
|
Comerica Securities |
|
Siebert Williams Shank |
|
WauBank Securities LLC |
The date of this prospectus supplement is February 26, 2024.